Institut Bergonié
🇫🇷France
- Country
- 🇫🇷France
- Ownership
- Private
- Established
- 1923-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.bergonie.org
Targeting ATR in Soft-tissue Sarcomas
Phase 2
Recruiting
- Conditions
- Leiomyosarcoma, Adult
- Interventions
- Drug: Association of berzosertib with gemcitabine
- First Posted Date
- 2021-03-19
- Last Posted Date
- 2023-09-28
- Lead Sponsor
- Institut Bergonié
- Target Recruit Count
- 72
- Registration Number
- NCT04807816
- Locations
- 🇫🇷
Institut Gustave Roussy, Villejuif, France
🇫🇷IUCT Oncopôle, Toulouse, France
🇫🇷Centre Leon Berard, Lyon, France
Combining Epigenetic And Immune Therapy to Beat Cancer.
Phase 2
Recruiting
- Conditions
- Adult Solid TumorAdvanced Soft-tissue SarcomaAdvanced Pancreatic AdenocarcinomaAdvanced Solid TumorAdvanced Colorectal Carcinoma
- Interventions
- First Posted Date
- 2021-01-12
- Last Posted Date
- 2023-03-01
- Lead Sponsor
- Institut Bergonié
- Target Recruit Count
- 173
- Registration Number
- NCT04705818
- Locations
- 🇫🇷
CHU Poitiers, Poitiers, France
🇫🇷Institut Bergonie, Bordeaux, France
🇫🇷CHRU Brest, Brest, France
Serological Response to SARS-Cov-2 Virus in Personnel of the Institut Bergonié in the Context of the COVID-19 Pandemic
Not Applicable
Completed
- Conditions
- Serum; DiseaseSars-CoV2
- Interventions
- Other: PRO-SERO-COV
- First Posted Date
- 2020-06-11
- Last Posted Date
- 2024-01-12
- Lead Sponsor
- Institut Bergonié
- Target Recruit Count
- 526
- Registration Number
- NCT04426006
- Locations
- 🇫🇷
Institut Bergonié, Bordeaux, France
Cryoablation in Combination (or Not) With Pembrolizumab and Pemetrexed-carboplatin in 1st-line Treatment for Patients With Metastatic Lung Adenocarcinoma
Phase 3
Recruiting
- Conditions
- Cryotherapy EffectLung Adenocarcinoma
- Interventions
- First Posted Date
- 2020-04-09
- Last Posted Date
- 2024-11-19
- Lead Sponsor
- Institut Bergonié
- Target Recruit Count
- 214
- Registration Number
- NCT04339218
- Locations
- 🇫🇷
Institut Bergonié, Bordeaux, Gironde, France
Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study
Not Applicable
Recruiting
- Conditions
- Non Small Cell Lung CancerColorectal Cancer
- Interventions
- Genetic: Liquid biopsy
- First Posted Date
- 2020-02-06
- Last Posted Date
- 2023-03-02
- Lead Sponsor
- Institut Bergonié
- Target Recruit Count
- 332
- Registration Number
- NCT04258137
- Locations
- 🇫🇷
Centre hospitalier de la Côte Basque, Bayonne, France
🇫🇷Institut Bergonie, Bordeaux, France
🇫🇷Polyclinique Bordeaux Nord Aquitaine, Bordeaux, France
Diagnostic Performances of Preoperative Echo-guided Uterine Biopsy in the Management of Suspect Uterine Sarcoma Tumors (BIOPSAR)
Not Applicable
Active, not recruiting
- Conditions
- Fibroid UterusSarcoma Uterus
- Interventions
- Procedure: Echo-guided uterine biopsy
- First Posted Date
- 2020-01-31
- Last Posted Date
- 2024-11-19
- Lead Sponsor
- Institut Bergonié
- Target Recruit Count
- 19
- Registration Number
- NCT04250766
- Locations
- 🇫🇷
Institut Bergonié, Bordeaux, France
Combination of Nivolumab Plus Relatlimab in Patients With Advanced or Metastatic Soft-tissue Sarcoma: a Proof-of-concept Randomized Phase II Study
Phase 2
Recruiting
- Conditions
- Advanced CancerSoft Tissue Sarcoma Adult
- Interventions
- Drug: Association of Nivolumab + Relatlimab
- First Posted Date
- 2019-09-19
- Last Posted Date
- 2023-02-22
- Lead Sponsor
- Institut Bergonié
- Target Recruit Count
- 67
- Registration Number
- NCT04095208
- Locations
- 🇫🇷
Institut Bergonié, Bordeaux, France
🇫🇷Institut de Cancérologie de l'Ouest - Site René Gauducheau, Nantes, France
🇫🇷Centre Léon Bérard, Lyon, France
MOLecular Characterization and Treatment of THYroid Carcinoma on Struma Ovarii
- Conditions
- Ovarian Cancer
- Interventions
- Other: DNA and RNA extraction from FFPE or frozen tissue sample
- First Posted Date
- 2019-08-12
- Last Posted Date
- 2019-08-12
- Lead Sponsor
- Institut Bergonié
- Target Recruit Count
- 20
- Registration Number
- NCT04053114
- Locations
- 🇫🇷
Institut Bergonié, Bordeaux, Aquitaine, France
Role of FDG-PET CT in the Management of Muscle Invasive Bladder Cancer
- Conditions
- Muscle Invasive Bladder Cancer
- First Posted Date
- 2019-08-12
- Last Posted Date
- 2019-08-12
- Lead Sponsor
- Institut Bergonié
- Target Recruit Count
- 130
- Registration Number
- NCT04053101
- Locations
- 🇫🇷
Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France
🇫🇷Institut Bergonie, Bordeaux, France
A Retrospective Study to Determine the Incidence of NTRK Fusions. NTRK Study
Completed
- Conditions
- Metastatic Solid Tumors
- Interventions
- Other: Retrospective cohort
- First Posted Date
- 2019-07-08
- Last Posted Date
- 2022-08-29
- Lead Sponsor
- Institut Bergonié
- Target Recruit Count
- 3820
- Registration Number
- NCT04010240
- Locations
- 🇫🇷
Institut Bergonié, Bordeaux, Aquitaine, France
© Copyright 2025. All Rights Reserved by MedPath